HANDOK Inc. (KRX:002390)
11,860
-30 (-0.25%)
At close: Dec 5, 2025
HANDOK Revenue
HANDOK had revenue of 144.68B KRW in the quarter ending September 30, 2025, with 12.12% growth. This brings the company's revenue in the last twelve months to 516.37B, up 0.72% year-over-year. In the year 2024, HANDOK had annual revenue of 507.36B, down -2.94%.
Revenue (ttm)
516.37B
Revenue Growth
+0.72%
P/S Ratio
0.30
Revenue / Employee
549.33M
Employees
940
Market Cap
154.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 507.36B | -15.38B | -2.94% |
| Dec 31, 2023 | 522.74B | -21.02B | -3.87% |
| Dec 31, 2022 | 543.76B | 26.12B | 5.05% |
| Dec 31, 2021 | 517.64B | 14.03B | 2.79% |
| Dec 31, 2020 | 503.61B | 30.61B | 6.47% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| Peptron | 6.19B |